Harrow (HROW) Non-Current Debt (2011 - 2026)

Harrow's (HROW) quarterly Non-Current Debt came in at $292.1 million in Q1 2026, up 159.63% year-on-year from $112.5 million in Q1 2025, and up 20.11% quarter-over-quarter from $243.2 million in Q4 2025.

Harrow (HROW) Non-Current Debt (2011 - 2026) Analysis & Trends

Harrow's Non-Current Debt history runs 13 years deep, the most recent figure standing at $292.1 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 159.63% year-over-year to $292.1 million in Q1 2026; TTM through Mar 2026 was $292.1 million, a 159.63% increase from a year earlier, with the FY2025 full-year figure at $243.2 million, up 10.77% from the prior year.
  • Non-Current Debt rose to $292.1 million in Q1 2026 per HROW's latest filing, from $243.2 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $292.1 million in Q1 2026 and bottomed at $38.5 million in Q2 2025.
  • The 5-year median for Non-Current Debt is $182.2 million (2023), against an average of $160.6 million.
  • Across the five-year window, Non-Current Debt surged 553.39% in 2022 and slumped 79.2% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $104.2 million in 2022, then jumped by 78.44% to $185.9 million in 2023, then increased by 18.1% to $219.5 million in 2024, then gained by 10.77% to $243.2 million in 2025, then rose by 20.11% to $292.1 million in 2026.
  • Per Business Quant, the three latest HROW Non-Current Debt figures stand at $292.1 million (Q1 2026), $243.2 million (Q4 2025), and $242.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 292.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 292.09 Mn
Dec 31, 2025 243.18 Mn
Sep 30, 2025 242.87 Mn
Jun 30, 2025 38.48 Mn
Mar 31, 2025 112.50 Mn
Dec 31, 2024 219.54 Mn
Sep 30, 2024 186.06 Mn
Jun 30, 2024 185.02 Mn
Mar 31, 2024 184.15 Mn
Dec 31, 2023 185.89 Mn
Sep 30, 2023 182.19 Mn
Jun 30, 2023 169.71 Mn
Mar 31, 2023 168.85 Mn
Dec 31, 2022 104.17 Mn
Sep 30, 2022 72.24 Mn
Jun 30, 2022 72.04 Mn
Mar 31, 2022 71.85 Mn
Dec 31, 2021 71.65 Mn
Sep 30, 2021 71.46 Mn
Jun 30, 2021 71.27 Mn